Medicine
Granisetron 1 mg tablet
Granisetron 1 mg tablet is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store between 20º to 25ºC (68º and 77ºF). Protect from light.
Key facts
- Active ingredient (INN)
- Granisetron
- Brand
- Sold under the generic name
- Strength
- 1 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 10 tablets, 2 tablets, 2 blister pack and 4 more
- Manufacturers
- Natco PharmaIndiaBionpharmaBreckenridge Pharmaceutical
- Origin register
- US FDA, United States
- Storage
- Store between 20º to 25ºC (68º and 77ºF). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A04AA02 Granisetron
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 22 June 2009
- Identifiers
- RxCUI 310599DailyMed set ID d2be8de3-04fe-4e92-82b4-98d749b89596, df4b6775-4337-41e0-815a-b064d98c3fe1, 50b713d3-7ca8-465a-aefa-65ddbe17b934NDC 63850-0005, 51991-735, 69452-350Application ANDA078969, ANDA078678
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 tablet, film coated in 1 blister pack | 63850-0005-1 | Natco PharmaIndia | 22 June 2009 |
| 2 tablet, film coated in 1 blister pack | 63850-0005-2 | Natco PharmaIndia | 22 June 2009 |
| 2 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack | 69452-350-01 | Bionpharma | 28 February 2022 |
| 20 tablet, film coated in 1 bottle, plastic | 69452-350-11 | Bionpharma | 28 February 2022 |
| 2 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 69452-350-92 | Bionpharma | 28 February 2022 |
| 2 blister pack in 1 carton / 10 tablet in 1 blister pack | 51991-735-20 | Breckenridge Pharmaceutical | 22 June 2009 |
| 1 blister pack in 1 carton / 2 tablet in 1 blister pack | 51991-735-32 | Breckenridge Pharmaceutical | 22 June 2009 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Granisetron
Clinical summary
Granisetron is a serotonin-3 receptor antagonist indicated for the prevention of nausea and vomiting in adults receiving moderately and/or highly emetogenic chemotherapy regimens of up to 5 consecutive days duration. MedsAcross supplies Granisetron for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about GranisetronFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- SANCUSO prescribing information (Cumberland Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Sancuso: European public assessment report (EPAR) · European Medicines Agency
Need Granisetron 1 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.